The COVID-19 pandemic and population growth have led many states to scale back or eliminate Certificate of Need laws, which ...

It's no secret that Ozempic isn't going anywhere, but the weight loss drug category does seem to be rapidly evolving.

It's not too hard to understand why people hate prices. Prices, left to do their work, are signals—about value, about rarity, ...

The narrative that these online progressives clearly subscribe to and perpetuate is one where, in the United States ... the demand for healthcare far exceeds the supply of healthcare—leading ...

The senior living industry is at a critical juncture as 2025 begins, one expert told McKnight’s Senior Living.

The United States Food and Drug Administration says ... "FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 drugs, including semaglutide and ...

As patients increasingly “vote with their feet” based on factors such as access, affordability, safety and quality of care – consumer-centric healthcare organizations are driving more than ...

United Airlines Holdings, Inc. (NYSE:NASDAQ:UAL), one of the "Big 3" carriers in the United States with a market ... potentially disrupting the supply-demand balance in key markets.

In the United States, health is unfortunately not a human right — it is sometimes seen as a commodity. We want to extend access to health care to immigrants, who are excluded from the health ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The health care crisis is upon us. In response to soaring costs, a jumbled patchwork of insurance programs, and criti ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.